Beyond Air Schedules Third Fiscal Quarter 2026 Financial Results Conference Call and Webcast

Rhea-AI Summary

Beyond Air (NASDAQ: XAIR) will report third fiscal quarter 2026 financial results for the period ended December 31, 2025 on Friday, February 13, 2026. Management will host a conference call and webcast at 8:00 AM Eastern Time the same day. Investors can join by dialing the domestic number 1-877-407-0784 or the international number 1-201-689-8560 using Conference ID 13758405. A live webcast will be available via the company’s Events page, and an online replay will be posted about one hour after the call.

News Market Reaction – XAIR

-7.53%

13 alerts

-7.53% News Effect

+8.2% Peak Tracked

-10.3% Trough Tracked

-$952K Valuation Impact

$12M Market Cap

0.0x Rel. Volume

On the day this news was published, XAIR declined 7.53%, reflecting a notable negative market reaction. Argus tracked a peak move of +8.2% during that session. Argus tracked a trough of -10.3% from its starting point during tracking. Our momentum scanner triggered 13 alerts that day, indicating notable trading interest and price volatility. This price movement removed approximately $952K from the company's valuation, bringing the market cap to $12M at that time.

Data tracked by StockTitan Argus on the day of publication.

Key Figures

Earnings call date: February 13, 2026 Call time: 8:00 AM ET Domestic dial-in: 1-877-407-0784 +5 more

8 metrics

Earnings call date February 13, 2026 Q3 FY2026 results for quarter ended December 31, 2025

Call time 8:00 AM ET Third fiscal quarter 2026 conference call

Domestic dial-in 1-877-407-0784 Access number for earnings call

Q2 FY2026 revenue $1.8 million Quarter ended September 30, 2025 (10-Q)

Prior-year revenue $0.8 million Q2 prior year comparison (10-Q)

Net loss $8.3 million Q2 FY2026 net loss; EPS <b>$1.25</b> (10-Q)

Cash & equivalents $10.9 million Balance as of September 30, 2025 (10-Q)

Long-term debt $10.1 million Long-term debt, net, as of September 30, 2025 (10-Q)

Market Reality Check

Price: $0.7889 Vol: Volume 694,552 is far bel...

low vol

$0.7889 Last Close

Volume Volume 694,552 is far below the 20-day average of 22,287,387 (volume_relative 0.03). low

Technical Price 1.62 trades below the 200-day moving average at 2.65, reflecting a pressured longer-term trend.

Peers on Argus

XAIR fell 8.47% while peers showed mixed moves: DHAI -27.59%, SINT -1.4%, AIMD -...

XAIR fell 8.47% while peers showed mixed moves: DHAI -27.59%, SINT -1.4%, AIMD -1.6%, INBS +2.59%, NVNO +6.27%. With no peers in the momentum scanner and mixed directions, the move appears stock-specific rather than a broad Medical Devices rotation.

Previous Conferences,earnings Reports

5 past events · Latest: Oct 23 (Neutral)

Same Type Pattern 5 events

Date	Event	Sentiment	Move	Catalyst
Oct 23	Earnings call scheduling	Neutral	+4.0%	Announced Q2 FY2026 results release and 4:30 PM ET conference call details.
Jul 25	Earnings call scheduling	Neutral	-3.6%	Set date and time for Q1 FY2026 financial results call and webcast.
May 20	Earnings call scheduling	Neutral	+1.5%	Announced fiscal Q4 and full-year 2025 results release and investor call.
Jan 27	Earnings call scheduling	Neutral	-1.8%	Scheduled fiscal Q3 2025 results release and 4:30 PM ET conference call.
Oct 29	Earnings call scheduling	Neutral	+8.8%	Set timing for fiscal Q2 2025 earnings release and related investor webcast.

Pattern Detected

Scheduling earnings calls has historically produced modest, mixed single-day moves around these announcements, with an average move of about 3.93% and no clear directional bias.

Recent Company History

Over the past year, Beyond Air has regularly announced financial results conference calls, including fiscal Q2 and Q1 2026, fiscal year-end 2025, and prior quarterly results. These releases, all tagged “conferences,earnings”, typically paired standard dial-in details with timing for quarterly or annual reports. Single-day reactions to these scheduling notices have ranged from modest declines to gains, averaging 3.93%, suggesting traders have treated them as routine updates rather than major catalysts.

Historical Comparison

+3.9% avg move · This scheduling notice mirrors five prior conferences,earnings announcements, where average single-d...

conferences,earnings

+3.9%

Average Historical Move conferences,earnings

This scheduling notice mirrors five prior conferences,earnings announcements, where average single-day moves were about 3.93%, indicating routine market reactions to similar calls.

The company has consistently scheduled quarterly and year-end earnings calls, providing a regular cadence of financial updates from fiscal 2025 through fiscal 2026.

Regulatory & Risk Context

Active S-3 Shelf

Shelf Active

Active S-3 Shelf Registration 2025-09-30

Beyond Air has an active Form S-3/A shelf filed on 2025-09-30, amended mainly to update legal opinion exhibits while leaving other terms unchanged. A related 424B3 filing on 2025-12-16 reflects at least one instance of usage under this shelf.

Market Pulse Summary

The stock moved -7.5% in the session following this news. A negative reaction despite this being a r...

Analysis

The stock moved -7.5% in the session following this news. A negative reaction despite this being a routine scheduling announcement would fit a pattern where funding needs and past dilution weigh on sentiment. Recent disclosures highlighted ongoing net losses and reliance on external financing, which could heighten sensitivity ahead of Q3 FY2026 results. Weakness following such neutral news might reflect caution about upcoming financials rather than the call notice itself.

Key Terms

nitric oxide, webcast

2 terms

nitric oxide medical

"focused on harnessing the power of nitric oxide (NO) to improve the lives"

A simple signaling molecule made of one nitrogen and one oxygen atom that acts like a tiny messenger in the body, telling blood vessels to widen, controlling breathing and influencing immune responses. Investors care because products that deliver, mimic, or measure this gas—such as inhaled therapies, drugs that boost its effects, or diagnostic tests—can affect patient outcomes, regulatory approvals and market value; think of it as a traffic controller for blood and air flow whose tools can become investable medical products.

webcast technical

"conference call and webcast at 8:00 am Eastern Time the same day"

A webcast is a live or recorded online event where people watch or listen to presentations, announcements, or performances through the internet. It’s like a TV broadcast but over the internet, allowing viewers from anywhere to tune in in real time or later. Webcasts are important because they let companies share information quickly and widely with audiences around the world.

AI-generated analysis. Not financial advice.

GARDEN CITY, N.Y., Jan. 26, 2026 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) (“Beyond Air” or the “Company”), a commercial stage medical device and biopharmaceutical company focused on harnessing the power of nitric oxide (NO) to improve the lives of patients, today announced that it will report financial results for its third fiscal quarter ended December 31, 2025 on Friday, February 13, 2026. The Company's management team is scheduled to host a conference call and webcast at 8:00 am Eastern Time the same day.

Conference Call & Webcast
Friday, February 13th@ 8:00 AM ET
Domestic:	1-877-407-0784
International:	1-201-689-8560
Conference ID:	13758405
Webcast:	A webcast of the live conference call can be accessed by visiting the Events section of the Company’s website (click here) or directly (click here). An online replay will be available on the Company’s website or via the direct link an hour after the call.

About Beyond Air, Inc.
Beyond Air is a commercial-stage medical device and biopharmaceutical company dedicated to harnessing the power of endogenous and exogenous nitric oxide (NO) to improve the lives of patients suffering from respiratory illnesses, neurological disorders, and solid tumors. The Company has received FDA approval and CE Mark for its first system, LungFit PH, for the treatment of term and near-term neonates with hypoxic respiratory failure. Beyond Air is currently advancing its other revolutionary LungFit systems in clinical trials for the treatment of severe lung infections such as viral community-acquired pneumonia (including COVID-19) and nontuberculous mycobacteria (NTM).

Additionally, Beyond Cancer, Ltd., an affiliate of Beyond Air, is investigating ultra-high concentrations of NO with a proprietary delivery system to target certain solid tumors in the pre-clinical setting. For more information, visit www.beyondair.net.

CONTACTS:

Corey Davis, Ph.D.
LifeSci Advisors, LLC
Cdavis@lifesciadvisors.com
(212) 915-2577

FAQ

When will Beyond Air (XAIR) report Q3 fiscal 2026 results?

Beyond Air will report results for the quarter ended December 31, 2025 on Friday, February 13, 2026.

What time is the Beyond Air (XAIR) Q3 2026 conference call and webcast?

The management conference call and webcast is scheduled for 8:00 AM Eastern Time on February 13, 2026.

How do I join the Beyond Air (XAIR) conference call by phone?

Dial 1-877-407-0784 (domestic) or 1-201-689-8560 (international) and enter Conference ID 13758405.

Where can I access the Beyond Air (XAIR) live webcast and replay?

Access the live webcast via the company’s Events page; an online replay will be posted about one hour after the call.

Will Beyond Air (XAIR) provide a replay of the Q3 2026 earnings call?

Yes, an online replay will be available on the company website or via the direct webcast link roughly one hour after the live call.

What is the conference ID for Beyond Air (XAIR) Q3 2026 earnings call?

Use Conference ID 13758405 when joining the phone conference.